Atlas Trials

UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia

Clinical trial NCT05689008 · UNKNOWN

Trial details

NCT number
NCT05689008
Sponsor
Shanghai East Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Mesenchymal Stem CellCOVID-19 Pneumonia
Start date
2023-01-10
Primary completion
2023-03-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.